Farxiga, generic name Dapagliflozin, is one of the prescribed medicines to treat Type 2 Diabetes among patients. Belonging to the class of SGLT2 inhibitors, the drug used to control the blood sugar levels in the patients and help them in living a healthy life. Accompanied by exercise and healthy living habits, this drug was supposed to manage the side effects associated with Type 2 diabetes.
However, multiple patients have suffered from Farxiga side effects. These reports reflect a disturbing picture, where patients have suffered from life-threatening issues.
However, multiple patients have suffered from Farxiga side effects. These reports reflect a disturbing picture, where patients have suffered from life-threatening issues.
Some of the common complications include,
• Pain while urinating
• Dipping blood pressure
• Urinary Tract infections
• Dehydration
In some cases, patients (especially women) have developed rare but fatal Fournier's gangrene. In this condition, a bacterial infection grows in the tissues surrounding the muscles and nerve endings of the perineum region. It required surgery to remove the infected part, in order to save the life of the patient.
What is the FDA doing about it?
After multiple incidents of Fournier's gangrene recurrences and several other complications among patients on Farxiga, the FDA decided to look into the matter. They found that many patients **suffering from the Farxiga side effects** required hospitalization and multiple surgeries to fix the issues. Later on, they asked the drug manufacturers to include possible side effects of the drugs in the medical guides for the patients.
However, these steps cannot help existing victims of medicine. As per experts, such victims can sue the drug makers for potentially endangering their life. Victims can approach Invokana Lawsuit for more update on the matter. Visit http://invokanalawsuit.us/ or call (855)598-3998, to know more.